Answers are grounded in this paper and cite their sources.
Academic scientists and scientists employed by manufacturers of erythropoiesis-stimulating agents report opposite findings in studies of the existence of functional erythropoietin receptors on cancer cells.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: